White House vague on surprise billing, drug pricing bills
White House vague on surprise billing, drug pricing bills: Some observers and congressional staff see an ambiguous approach as leaving room for bipartisan dealmaking, while others worry that vague calls for action will not break stubborn gridlock.
No comments:
Post a Comment